Search

Author/Creator Caplanusi, Adrian

1. A phase III randomized, open-label, non-inferiority clinical trial comparing liquid and lyophilized formulations of oral live attenuated human rotavirus vaccine (HRV) in Indian infants. Issue 11 (2nd November 2021)

Authors:
Cohet, Catherine; Cheuvart, Brigitte; Moerman, Leentje; Bi, Dan; Caplanusi, Adrian; Kariyappa, Mallesh; Lalwani, Sanjay; Mitra, Monjori; Sapru, Amita; Saha, Shruti; Varughese, P.V.; Kompithra, Rajeev Zachariah; Gandhi, Sanjay
Journal:
Human vaccines & immunotherapeutics
Issue:
Volume 17:Issue 11(2021)
Page Start:
4646
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. An assessment of prime‐boost vaccination schedules with AS03A‐adjuvanted prepandemic H5N1 vaccines: a randomized study in European adults. Issue 1 (9th March 2012)

Authors:
Gillard, Paul; Caplanusi, Adrian; Knuf, Markus; Roman, François; Walravens, Karl; Moris, Philippe; Dramé, Mamadou; Schwarz, Tino F.
Journal:
Influenza and other respiratory viruses
Issue:
Volume 7:Issue 1(2013:Jan.)
Page Start:
55
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Immunogenicity and Safety of a Measles-Mumps-Rubella Vaccine Administered as a First Dose to Children Aged 12 to 15 Months: A Phase III, Randomized, Noninferiority, Lot-to-Lot Consistency Study. (8th March 2019)

Authors:
Klein, Nicola P; Abu-Elyazeed, Remon; Povey, Michael; Macias Parra, Mercedes; Diez-Domingo, Javier; Ahonen, Anitta; Korhonen, Tiina; Tinoco, Juan-Carlos; Weiner, Leonard; Marshall, Gary S; Silas, Peter E; Sarpong, Kwabena O; Ramsey, Keith P; Fling, John A; Speicher, David; Campos, Maribel; Munjal...
Journal:
Journal of the Pediatric Infectious Diseases Society
Issue:
Volume 9:Number 2(2020)
Page Start:
194
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Immunogenicity and safety of a second dose of a measles-mumps-rubella vaccine administered to healthy participants 7 years of age or older: A phase III, randomized study. Issue 11 (2nd November 2018)

Authors:
Abu-Elyazeed, Remon; Jennings, William; Severance, Randall; Noss, Michael; Caplanusi, Adrian; Povey, Michael; Henry, Ouzama
Journal:
Human vaccines & immunotherapeutics
Issue:
Volume 14:Issue 11(2018)
Page Start:
2624
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine in Children 6 Months to 17 Years of Age, Previously Vaccinated with an AS03-Adjuvanted A(H1N1)Pdm09 Vaccine. Issue 7 (July 2015)

Authors:
Vesikari, Timo; Richardus, Jan Hendrik; Berglund, Johan; Korhonen, Tiina; Flodmark, Carl-Erik; Lindstrand, Ann; Silfverdal, Sven Arne; Bambure, Vinod; Caplanusi, Adrian; Dieussaert, Ilse; Roy-Ghanta, Sumita; Vaughn, David W.
Journal:
Pediatric infectious disease journal
Issue:
Volume 34:Issue 7(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine in Children 6 Months to 17 Years of Age, Previously Vaccinated with an AS03-Adjuvanted A(H1N1)Pdm09 Vaccine: Two Open-label, Randomized Trials. Issue 7 (July 2015)

Authors:
Vesikari, Timo; Richardus, Jan Hendrik; Berglund, Johan; Korhonen, Tiina; Flodmark, Carl-Erik; Lindstrand, Ann; Silfverdal, Sven Arne; Bambure, Vinod; Caplanusi, Adrian; Dieussaert, Ilse; Roy-Ghanta, Sumita; Vaughn, David W.
Journal:
Pediatric infectious disease journal
Issue:
Volume 34:Issue 7(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗